$1.17 Billion is the total value of Nantahala Capital Management's 133 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 39.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Buy | ISHARES TRput | $194,414,000 | +48.3% | 1,100,000 | +57.1% | 16.61% | +31.0% |
ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $92,625,366 | -26.8% | 1,887,617 | +2.4% | 7.91% | -35.3% |
XBI | New | SPDR SER TRput | $69,369,000 | – | 950,000 | +100.0% | 5.93% | – |
CASH | Sell | PATHWARD FINANCIAL INC | $56,899,303 | -12.6% | 1,234,526 | -12.1% | 4.86% | -22.8% |
IMAX | Sell | IMAX CORP | $50,364,999 | +0.7% | 2,606,884 | -11.5% | 4.30% | -11.1% |
ESTA | New | ESTABLISHMENT LABS HLDGS INCcall | $28,411,530 | – | 579,000 | +100.0% | 2.43% | – |
LXFR | Sell | LUXFER HLDGS PLC | $27,681,164 | -12.5% | 2,121,162 | -4.6% | 2.36% | -22.7% |
RDVT | Sell | RED VIOLET INC | $25,250,539 | -3.2% | 1,261,896 | -0.5% | 2.16% | -14.5% |
KRE | New | SPDR SER TRput | $25,062,000 | – | 600,000 | +100.0% | 2.14% | – |
IMTX | Sell | IMMATICS N.V | $22,240,965 | -15.7% | 1,920,636 | -15.9% | 1.90% | -25.5% |
CRMT | Buy | AMERICAS CAR-MART INC | $21,014,413 | +98.4% | 230,953 | +117.5% | 1.80% | +75.1% |
HGV | Buy | HILTON GRAND VACATIONS INC | $20,522,649 | +2.4% | 504,242 | +14.4% | 1.75% | -9.5% |
QURE | Buy | UNIQURE NV | $20,289,691 | -37.9% | 3,023,799 | +6.1% | 1.73% | -45.1% |
BVS | Buy | BIOVENTUS INC | $19,861,156 | +22.3% | 6,018,532 | +7.1% | 1.70% | +8.1% |
PTON | Buy | PELOTON INTERACTIVE INC | $17,950,760 | +32.5% | 3,554,606 | +101.7% | 1.53% | +16.9% |
LYRA | Buy | LYRA THERAPEUTICS INC | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
VMD | Buy | VIEMED HEALTHCARE INC | $13,676,504 | -19.1% | 2,032,170 | +17.6% | 1.17% | -28.6% |
ASRT | New | ASSERTIO HOLDINGS INC | $11,955,200 | – | 4,670,000 | +100.0% | 1.02% | – |
NPCE | Buy | NEUROPACE INC | $11,869,773 | +522.2% | 1,219,915 | +187.1% | 1.01% | +451.1% |
Sell | SOLENO THERAPEUTICS INC | $11,579,842 | +315.4% | 392,404 | -39.6% | 0.99% | +266.3% | |
GDEN | Sell | GOLDEN ENTMT INC | $11,349,674 | -18.2% | 332,056 | -0.0% | 0.97% | -27.7% |
KMPH | New | ZEVRA THERAPEUTICS INC | $11,125,601 | – | 2,308,216 | +100.0% | 0.95% | – |
RMR | Sell | RMR GROUP INCcl a | $10,593,449 | -34.6% | 432,033 | -38.2% | 0.90% | -42.2% |
RH | RHcall | $10,574,400 | -19.8% | 40,000 | 0.0% | 0.90% | -29.2% | |
KROS | Sell | KEROS THERAPEUTICS INC | $10,481,538 | -47.5% | 328,781 | -33.9% | 0.90% | -53.7% |
HGV | New | HILTON GRAND VACATIONS INCcall | $10,175,000 | – | 250,000 | +100.0% | 0.87% | – |
PAYO | PAYONEER GLOBAL INC | $9,870,715 | +27.2% | 1,612,862 | 0.0% | 0.84% | +12.4% | |
RMBL | Buy | RUMBLEON INC | $9,841,053 | -37.4% | 1,605,392 | +26.3% | 0.84% | -44.7% |
Buy | ABEONA THERAPEUTICS INC | $9,673,713 | +71.2% | 2,297,794 | +63.9% | 0.83% | +51.3% | |
CDXS | Buy | CODEXIS INC | $9,581,247 | -32.0% | 5,069,443 | +0.7% | 0.82% | -40.0% |
AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $9,337,835 | +40.1% | 2,212,757 | +3.0% | 0.80% | +23.9% |
NDLS | Buy | NOODLES & CO | $8,599,734 | +154.4% | 3,495,827 | +249.6% | 0.74% | +124.8% |
HLF | HERBALIFE LTDcall | $8,394,000 | +5.7% | 600,000 | 0.0% | 0.72% | -6.6% | |
MLHR | Sell | MILLERKNOLL INC | $8,318,575 | -7.4% | 340,228 | -44.0% | 0.71% | -18.2% |
TALS | Buy | TALARIS THERAPEUTICS INC | $8,298,292 | +88.3% | 2,953,129 | +103.7% | 0.71% | +66.4% |
DHX | Sell | DHI GROUP INC | $8,256,495 | -28.9% | 2,698,201 | -11.0% | 0.70% | -37.2% |
Sell | DARIOHEALTH CORP | $7,918,549 | -18.4% | 2,414,192 | -0.2% | 0.68% | -27.9% | |
Buy | AMYLYX PHARMACEUTICALS INC | $7,455,924 | +110.1% | 407,205 | +147.5% | 0.64% | +85.7% | |
ZM | ZOOM VIDEO COMMUNICATIONS INcall | $6,994,000 | +3.0% | 100,000 | 0.0% | 0.60% | -9.0% | |
ILPT | INDUSTRIAL LOGISTICS PPTYS T | $6,812,551 | -12.4% | 2,357,284 | 0.0% | 0.58% | -22.6% | |
Sell | AURA BIOSCIENCES INC | $6,672,711 | -32.7% | 743,892 | -7.4% | 0.57% | -40.6% | |
DXPE | Sell | DXP ENTERPRISES INC | $6,288,746 | -19.2% | 179,987 | -15.8% | 0.54% | -28.6% |
DYN | Buy | DYNE THERAPEUTICS INC | $6,121,149 | -8.3% | 683,164 | +15.2% | 0.52% | -18.9% |
RDI | Sell | READING INTL INCcl a | $6,097,205 | -20.3% | 2,876,040 | -0.3% | 0.52% | -29.5% |
New | RESERVOIR MEDIA INC | $6,016,601 | – | 986,328 | +100.0% | 0.51% | – | |
EHTH | EHEALTH INC | $5,920,000 | -8.0% | 800,000 | 0.0% | 0.51% | -18.6% | |
NSPR | Sell | INSPIREMD INC | $5,781,524 | +23.8% | 1,768,050 | -5.0% | 0.49% | +9.3% |
New | AN2 THERAPEUTICS INC | $5,737,167 | – | 356,789 | +100.0% | 0.49% | – | |
COGT | Buy | COGENT BIOSCIENCES INC | $5,606,250 | +638.3% | 575,000 | +796.6% | 0.48% | +556.2% |
RH | New | RH | $5,512,699 | – | 20,853 | +100.0% | 0.47% | – |
CYTK | CYTOKINETICS INC | $5,280,911 | -9.7% | 179,257 | 0.0% | 0.45% | -20.2% | |
Sell | VENTYX BIOSCIENCES INC | $5,126,947 | -18.9% | 147,623 | -23.4% | 0.44% | -28.3% | |
GOSS | New | GOSSAMER BIO INC | $5,071,311 | – | 6,089,471 | +100.0% | 0.43% | – |
KRTX | KARUNA THERAPEUTICS INCcall | $5,072,700 | -22.0% | 30,000 | 0.0% | 0.43% | -31.2% | |
IMAX | IMAX CORPcall | $4,830,000 | +13.7% | 250,000 | 0.0% | 0.41% | +0.5% | |
New | DIANTHUS THERAPEUTICS INC | $4,604,904 | – | 336,862 | +100.0% | 0.39% | – | |
GMDA | New | GAMIDA CELL LTD | $4,454,750 | – | 4,325,000 | +100.0% | 0.38% | – |
XTNT | New | XTANT MED HLDGS INC | $4,400,000 | – | 4,000,000 | +100.0% | 0.38% | – |
BXMT | Sell | BLACKSTONE MTG TR INCput | $4,350,000 | -47.7% | 200,000 | -50.0% | 0.37% | -53.8% |
VNDA | New | VANDA PHARMACEUTICALS INC | $4,320,000 | – | 1,000,000 | +100.0% | 0.37% | – |
PAR TECHNOLOGY CORPnote 2.875% 4/1 | $4,310,358 | +6.5% | 3,785,000 | 0.0% | 0.37% | -6.1% | ||
PTON | Buy | PELOTON INTERACTIVE INCcall | $4,302,600 | -28.3% | 852,000 | +9.2% | 0.37% | -36.6% |
SBTX | Buy | ARS PHARMACEUTICALS INC | $4,154,504 | +244.3% | 1,099,075 | +510.3% | 0.36% | +203.4% |
OPTN | Buy | OPTINOSE INC | $4,068,769 | +23.4% | 3,307,942 | +23.4% | 0.35% | +9.1% |
IDYA | IDEAYA BIOSCIENCES INC | $3,935,303 | +14.8% | 145,860 | 0.0% | 0.34% | +1.5% | |
SVRA | New | SAVARA INC | $3,928,796 | – | 1,039,364 | +100.0% | 0.34% | – |
ALTG | Sell | ALTA EQUIPMENT GROUP INC | $3,890,942 | -46.9% | 322,632 | -23.7% | 0.33% | -53.2% |
AGS | Buy | PLAYAGS INC | $3,876,622 | +24.2% | 594,574 | +7.6% | 0.33% | +9.6% |
IWM | Sell | ISHARES TRrussell 2000 etf | $3,866,718 | -63.6% | 21,878 | -61.4% | 0.33% | -67.8% |
EOLS | New | EVOLUS INC | $3,849,951 | – | 421,220 | +100.0% | 0.33% | – |
TELA | Buy | TELA BIO INC | $3,648,736 | +1.2% | 456,092 | +28.1% | 0.31% | -10.6% |
ASPS | New | ALTISOURCE PORTFOLIO SOLNS S | $3,608,803 | – | 904,462 | +100.0% | 0.31% | – |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $3,485,250 | -48.5% | 240,031 | -25.7% | 0.30% | -54.4% |
PNT | Sell | POINT BIOPHARMA GLOBAL INC | $3,476,344 | -32.9% | 521,191 | -8.9% | 0.30% | -40.7% |
INMD | New | INMODE LTDput | $3,046,000 | – | 100,000 | +100.0% | 0.26% | – |
Buy | UNICYCIVE THERAPEUTICS INC | $2,984,666 | +260.2% | 3,470,541 | +436.1% | 0.26% | +218.8% | |
AYTU BIOPHARMA INC | $2,934,392 | +68.7% | 1,086,812 | 0.0% | 0.25% | +49.4% | ||
SNDX | New | SYNDAX PHARMACEUTICALS INCcall | $2,904,000 | – | 200,000 | +100.0% | 0.25% | – |
ENVA | ENOVA INTL INC | $2,708,828 | -4.2% | 53,250 | 0.0% | 0.23% | -15.7% | |
PWP | PERELLA WEINBERG PARTNERS | $2,629,219 | +22.2% | 258,273 | 0.0% | 0.22% | +8.2% | |
RILY | B. RILEY FINANCIAL INC | $2,562,695 | -10.9% | 62,520 | 0.0% | 0.22% | -21.2% | |
NNBR | Buy | NN INC | $2,516,846 | +100.2% | 1,353,143 | +157.2% | 0.22% | +76.2% |
TARS | New | TARSUS PHARMACEUTICALS INC | $2,407,835 | – | 135,500 | +100.0% | 0.21% | – |
CDTX | Sell | CIDARA THERAPEUTICS INC | $2,391,686 | -46.6% | 2,538,406 | -35.9% | 0.20% | -52.9% |
AZYO | New | ELUTIA INC | $2,359,500 | – | 1,650,000 | +100.0% | 0.20% | – |
SELB | Buy | SELECTA BIOSCIENCES INC | $2,332,000 | +108.2% | 2,200,000 | +120.0% | 0.20% | +84.3% |
FOSL | Buy | FOSSIL GROUP INC | $2,029,543 | -14.2% | 985,215 | +7.1% | 0.17% | -24.5% |
IMTXW | Sell | IMMATICS N.V*w exp 07/01/202 | $1,978,779 | -38.8% | 558,977 | -43.3% | 0.17% | -46.0% |
SSKN | Sell | STRATA SKIN SCIENCES INC | $1,942,642 | -53.5% | 3,264,945 | -25.7% | 0.17% | -58.9% |
MAX | Sell | MEDIAALPHA INCcl a | $1,935,913 | -83.6% | 234,372 | -79.5% | 0.16% | -85.5% |
CCCC | C4 THERAPEUTICS INC | $1,860,000 | -32.4% | 1,000,000 | 0.0% | 0.16% | -40.2% | |
FBIO | Sell | FORTRESS BIOTECH INC | $1,747,087 | -50.3% | 6,018,211 | -5.8% | 0.15% | -56.2% |
SRL | Sell | SCULLY ROYALTY LTD | $1,689,459 | -23.6% | 298,491 | -1.7% | 0.14% | -32.7% |
Sell | JASPER THERAPEUTICS INC | $1,682,033 | -50.5% | 2,402,904 | -3.0% | 0.14% | -56.1% | |
ANEB | ANEBULO PHARMACEUTICALS INC | $1,561,328 | +30.0% | 511,073 | 0.0% | 0.13% | +14.7% | |
EHTH | EHEALTH INCcall | $1,502,940 | -8.0% | 203,100 | 0.0% | 0.13% | -19.0% | |
AAN | THE AARONS COMPANY INC | $1,450,849 | -26.0% | 138,572 | 0.0% | 0.12% | -34.4% | |
AVTE | AEROVATE THERAPEUTICS INC | $1,289,150 | -20.9% | 95,000 | 0.0% | 0.11% | -30.4% | |
TGTX | New | TG THERAPEUTICS INC | $1,254,000 | – | 150,000 | +100.0% | 0.11% | – |
RMBL | Sell | RUMBLEON INCcall | $1,226,000 | -80.2% | 200,000 | -60.0% | 0.10% | -82.4% |
New | NEOLEUKIN THERAPEUTICS INC | $1,184,996 | – | 299,999 | +100.0% | 0.10% | – | |
NMTC | New | NEUROONE MED TECHNOLOGIES CO | $1,113,000 | – | 1,250,000 | +100.0% | 0.10% | – |
RZLT | REZOLUTE INC | $1,015,880 | -33.3% | 769,606 | 0.0% | 0.09% | -40.8% | |
QURE | Sell | UNIQURE NVcall | $991,067 | -77.7% | 147,700 | -61.9% | 0.08% | -80.2% |
Buy | JOURNEY MED CORP | $955,337 | +236.2% | 348,663 | +95.1% | 0.08% | +203.7% | |
TBBK | Sell | BANCORP INC DEL | $858,912 | -93.6% | 24,896 | -93.9% | 0.07% | -94.3% |
SGRP | Buy | SPAR GROUP INC | $846,747 | -11.3% | 879,189 | +16.0% | 0.07% | -21.7% |
ACER | Sell | ACER THERAPEUTICS INC | $748,454 | -28.7% | 918,349 | -19.2% | 0.06% | -36.6% |
New | ACELRX PHARMACEUTICALS INC | $680,349 | – | 1,173,015 | +100.0% | 0.06% | – | |
REPH | New | SOCIETAL CDMO INC | $586,250 | – | 1,250,000 | +100.0% | 0.05% | – |
SRTS | SENSUS HEALTHCARE INC | $512,583 | -12.1% | 185,048 | 0.0% | 0.04% | -21.4% | |
TIL | New | INSTIL BIO INC | $428,000 | – | 1,000,000 | +100.0% | 0.04% | – |
New | ACELRX PHARMACEUTICALS INCcall | $437,900 | – | 755,000 | +100.0% | 0.04% | – | |
KROS | KEROS THERAPEUTICS INCcall | $392,124 | -20.7% | 12,300 | 0.0% | 0.03% | -31.2% | |
Sell | APTOSE BIOSCIENCES INC | $382,152 | -43.7% | 136,483 | -6.7% | 0.03% | -50.0% | |
LADR | LADDER CAP CORPcl a | $277,769 | -5.4% | 27,073 | 0.0% | 0.02% | -14.3% | |
Sell | ELICIO THERAPEUTICS INC | $253,500 | -71.9% | 30,000 | -68.4% | 0.02% | -74.7% | |
XGN | Sell | EXAGEN INC | $258,381 | -26.9% | 106,769 | -12.4% | 0.02% | -35.3% |
ADCT | Sell | ADC THERAPEUTICS SA | $230,674 | -87.2% | 257,162 | -69.4% | 0.02% | -88.6% |
Buy | ABEONA THERAPEUTICS INCcall | $218,920 | +171.6% | 52,000 | +160.0% | 0.02% | +137.5% | |
TACT | Sell | TRANSACT TECHNOLOGIES INC | $199,713 | -43.6% | 31,108 | -21.2% | 0.02% | -50.0% |
Sell | LUCID DIAGNOSTICS INC | $185,018 | -33.1% | 158,135 | -20.6% | 0.02% | -40.7% | |
BMTX | BM TECHNOLOGIES INC | $158,424 | -32.9% | 79,212 | 0.0% | 0.01% | -39.1% | |
RFL | RAFAEL HLDGS INC | $138,088 | -9.1% | 72,678 | 0.0% | 0.01% | -20.0% | |
Sell | AKUMIN INC | $142,865 | -57.9% | 979,196 | -48.1% | 0.01% | -63.6% | |
New | KINTARA THERAPEUTICS INC | $91,381 | – | 22,619 | +100.0% | 0.01% | – | |
CUE | CUE BIOPHARMA INC | $61,548 | -37.0% | 26,760 | 0.0% | 0.01% | -44.4% | |
GAIA | GAIA INC NEWcl a | $62,952 | +17.7% | 23,144 | 0.0% | 0.01% | 0.0% | |
GUARDFORCE AI CO LTD*w exp 10/01/202 | $53,972 | +6.1% | 154,205 | 0.0% | 0.01% | 0.0% | ||
CBIO | CATALYST BIOSCIENCES INC | $32,700 | +37.2% | 67,800 | 0.0% | 0.00% | +50.0% | |
NOGIN INC | $29,962 | -59.5% | 56,425 | 0.0% | 0.00% | -57.1% | ||
NOGIN INC*w exp 08/26/202 | $13,291 | -88.1% | 330,000 | 0.0% | 0.00% | -90.9% | ||
TC BIOPHARM HOLDINGS PLC*w exp 02/08/202 | $5,176 | -48.8% | 235,294 | 0.0% | 0.00% | -100.0% | ||
IMAC | Exit | IMAC HLDGS INC | $0 | – | -53,918 | -100.0% | -0.00% | – |
FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -21,370 | -100.0% | -0.01% | – |
Exit | EBET INC | $0 | – | -1,065,432 | -100.0% | -0.01% | – | |
Exit | AVALO THERAPEUTICS INC | $0 | – | -556,202 | -100.0% | -0.02% | – | |
Exit | EARGO INC | $0 | – | -54,002 | -100.0% | -0.03% | – | |
CVNA | Exit | CARVANA COcl a | $0 | – | -25,000 | -100.0% | -0.06% | – |
Exit | BERKSHIRE GREY INC | $0 | – | -500,000 | -100.0% | -0.07% | – | |
TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -1,251,139 | -100.0% | -0.08% | – |
DHC | Exit | DIVERSIFIED HEALTHCARE TR | $0 | – | -395,613 | -100.0% | -0.09% | – |
SCYX | Exit | SCYNEXIS INC | $0 | – | -300,000 | -100.0% | -0.09% | – |
TNL | Exit | TRAVEL PLUS LEISURE CO | $0 | – | -23,016 | -100.0% | -0.09% | – |
MACK | Exit | MERRIMACK PHARMACEUTICALS IN | $0 | – | -111,148 | -100.0% | -0.13% | – |
AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -4,101,193 | -100.0% | -0.18% | – |
Exit | STRUCTURE THERAPEUTICS INCsponsored ads | $0 | – | -50,000 | -100.0% | -0.20% | – | |
UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -15,700 | -100.0% | -0.34% | – |
MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -5,000,000 | -100.0% | -0.37% | – |
CVNA | Exit | CARVANA COcall | $0 | – | -150,000 | -100.0% | -0.38% | – |
CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -553,307 | -100.0% | -0.59% | – |
IWM | Exit | ISHARES TRcall | $0 | – | -50,000 | -100.0% | -0.90% | – |
AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -4,272,203 | -100.0% | -0.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 27.2% |
CODEXIS INC | 42 | Q3 2023 | 3.9% |
PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
QAD INC | 32 | Q3 2021 | 2.6% |
SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-21 |
4 | 2024-03-15 |
SC 13G | 2024-03-11 |
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.